id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-P-0582-0006,FDA,FDA-2010-P-0582,"FDA/CDER to Lachman Consultant Services, Inc. - Petition Approval",Other,Grant of Petition,2012-03-29T04:00:00Z,2012,3,2012-03-29T04:00:00Z,,2012-03-29T16:13:34Z,,0,0,0900006480fe42db
FDA-2010-P-0582-0005,FDA,FDA-2010-P-0582,"Acknowledgement Letter to Lachman Consultant Services, Inc.",Other,ACK-Acknowledgement Letter,2010-12-27T05:00:00Z,2010,12,2010-12-27T05:00:00Z,,2013-07-27T23:37:21Z,,0,0,0900006480b8a212
FDA-2010-P-0582-0003,FDA,FDA-2010-P-0582,"Attachment 2 - ""Description Information, Mercaptopurine Tablets, USP"" - [Lachman Consultant Services, Inc. - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2010-12-27T05:00:00Z,2010,12,,,2010-12-27T18:31:36Z,,0,0,0900006480b8a0c0
FDA-2010-P-0582-0002,FDA,FDA-2010-P-0582,"Attachment 1 ""Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations"" - [Lachman Consultant Services, Inc. - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2010-12-27T05:00:00Z,2010,12,,,2010-12-27T18:31:35Z,,0,0,0900006480b8a0bf
FDA-2010-P-0582-0004,FDA,FDA-2010-P-0582,"Attachment 3 - ""Description Information, Purinethol - Mercaptopurine Tablets, Gate Pharmaceuticals"" - [Lachman Consultant Services, Inc. - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2010-12-27T05:00:00Z,2010,12,,,2010-12-27T18:31:38Z,,0,0,0900006480b8a15d
FDA-2010-P-0582-0001,FDA,FDA-2010-P-0582,"Lachman Consultant Services, Inc. - Citizen Petition",Other,CP-Citizen Petition,2010-12-27T05:00:00Z,2010,12,2010-12-27T05:00:00Z,,2024-11-12T04:55:42Z,,1,0,0900006480b88126